The role of disulfide bonds in the structure and function of murine epidermal growth factor (mEGF)

Growth Factors

Volumn 23, Issue 2, 2005, Pages 97-110

  Alewood, Dianne ^a   Nielsen, Kathy ^a   Alewood, Paul F ^a   Craik, David J ^a   Andrews, Peter ^a   Nerrie, Maureen ^b,c   White, Sara ^b   Domagala, Teresa ^b,c   Walker, Francesca ^b,c   Rothacker, Julie ^b,c   Burgess, Antony W ^b,c   Nice, Edouard C ^b,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c The CRC for Cellular Growth Factors   (Australia)

Author keywords

Disulfide bond; EGF; EGF receptor; Mitogenic activity; NMR; Structure function

Indexed keywords

2 AMINOBUTYRIC ACID; CYSTEINE; DIMETHYL SULFOXIDE; DISULFIDE; EPIDERMAL GROWTH FACTOR; AMINOBUTYRIC ACID DERIVATIVE; OXYGEN; PEPTIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISULFIDE BOND; FIBROBLAST; MASS SPECTROMETRY; MITOGENICITY; MOUSE; MOUSE STRAIN; NONHUMAN; OXIDATION; PEPTIDE SYNTHESIS; PH; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; CHEMICAL STRUCTURE; CHEMISTRY; CIRCULAR DICHROISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; PROTEIN FOLDING; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY; TIME;

ANIMALIA; MURINAE;

AMINO ACID SEQUENCE; AMINOBUTYRIC ACIDS; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCULAR DICHROISM; CYSTEINE; DISULFIDES; EPIDERMAL GROWTH FACTOR; HUMANS; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MICE; MICE, INBRED BALB C; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; OXYGEN; PEPTIDES; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; TIME FACTORS;

EID: 24944478764     PISSN: 08977194     EISSN: None     Source Type: Journal    
DOI: 10.1080/08977190500096061     Document Type: Article

References (89)

1. Alroy, I, Yarden, Y. The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions FEBS Lett, 1997; 410: 83-86
2. Araki, F, Nakamura, H, Nojima, N, Tsukumo, K, Sakamoto, S. Stability of recombinant human epidermal growth factor in various solutions Chem Pharm Bull (Tokyo), 1989; 37: 404-406
3. Ball, HL, King, DS, Cohen, FE, Prusiner, SB, Baldwin, MA. Engineering the prion protein using chemical synthesis J Peptide Res, 2001; 58: 357
4. Barnham, KJ, Torres, AM, Alewood, D, Alewood, PF, Domagala, T, Nice, EC, Norton, RS. Role of the 6-20 disulfide bridge in the structure and activity of epidermal growth factor Protein Sci, 1998; 7: 1738-1749
5. Bax, A, Davis, DG. MILEV-17 based two dimensional homonuclear magnetization transfer spectroscopy J Magn Reson, 1985; 65: 355-360
6. Bewley, TA, Brovetto-Cruz, J, Li, CH. Human pituitary growth hormone. Physicochemical investigations of the native and reduced-alkylated protein Biochemistry, 1969; 8: 4701-4708
7. Brems, DN, Brown, PL, Becker, GW. Equilibrium denaturation of human growth hormone and its cysteine-modified forms J Biol Chem, 1990; 265: 5504-5511
8. Burgess, AW, Sizeland, AM. Growth factors and the gut J Gastroenterol Hepatol, 1990; 5: 10-21
9. Burgess, AW, Knesel, J, Sparrow, LG, Nicola, NA, Nice, EC. Two forms of murine epidermal growth factor: Rapid separation by using reverse-phase high performance liquid chromatography Proc Natl Acad Sci USA, 1982; 79: 5753-5757
10. Burgess, AW, Lloyd, CJ, Nice, EC. Murine epidermal growth factor: Heterogeneity on high resolution ion-exchange chromatography EMBO J, 1983; 2: 2065-2069
11. Burgess, AW, Lloyd, CJ, Smith, S, Stanley, E, Walker, F, Fabri, L, Simpson, RJ, Nice, EC. Murine epidermal growth factor: Structure and function Biochemistry, 1988; 27: 4977-4985
12. Burgess, AW, Cho, HS, Eigenbrot, C, Ferguson, KM, Garrett, TP, Leahy, DJ, Lemmon, MA, Sliwkowski, MX, Ward, CW, Yokoyama, S. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors Mol Cell, 2003; 12: 541-552
13. Campbell, ID, Cooke, RM, Baron, M, Harvey, TS, Tappin, MJ. The solution structures of epidermal growth factor and transforming growth factor alpha Prog Growth Factor Res, 1989; 1: 13-22
14. Carver, JA, Cooke, RM, Esposito, G, Campbell, D, Gregory, H, Sheard, B. A high resolution 1H NMR study of the solution structure of human epidermal growth factor FEBS Lett, 1986; 205: 77-81
15. Chang, JY, Schindler, P, Ramseier, U, Lai, PH. The disulfide folding pathway of human epidermal growth factor J Biol Chem, 1995; 270: 9207-9216
16. Chang, JY, Li, L, Lai, PH. A major kinetic trap for the oxidative folding of human epidermal growth factor J Biol Chem, 2001; 276: 4845-4852
17. Cho, HS, Leahy, DJ. Structure of the extracellular region of HER3 reveals an interdomain tether Science, 2002; 297: 1330-1333
18. Cho, HS, Mason, K, Ramyar, KX, Stanley, AM, Gabelli, SB, Denney, DW, Leahy, DJ. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab Nature, 2003; 421: 756-760
19. Cooke, RM, Wilkinson, AJ, Baron, M. The solution structure of human epidermal growth factor Nature, 1987; 327: 339-341 et al.
20. Defeo-Jones, D, Tai, JY, Wegrzyn, RJ, Vuocolo, GA, Baker, AE, Payne, LS, Garsky, VM, Oliff, A, Riemen, MW. Structure-function analysis of synthetic and recombinant derivatives of transforming growth factor alpha Mol Cell Biol, 1988; 8: 2999-3007
21. Domagala, T, Konstantopoulos, N, Smyth, F, Jorissen, RN, Fabri, L, Geleick, D, Lax, I, Schlessinger, J, Sawyer, W, Howlett, GJ, Burgess, AW, Nice, EC. Stoichiometry, kinetic and binding analysis of the interaction between epidermal growth factor (EGF) and the extracellular domain of the EGF receptor Growth Factors, 2000; 18: 11-29
22. Ellman, GL. Tissue sulfhydryl groups Arch Biochem Biophys, 1959; 82: 70-77
23. Ferguson, KM, Berger, MB, Mendrola, JM, Cho, HS, Leahy, DJ, Lemmon, MA. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization Mol Cell, 2003; 11: 507-517
24. Ferrer, M, Woodward, C, Barany, G. Solid-phase synthesis of bovine pancreatic trypsin inhibitor (BPTI) and two analogues. A chemical approach for evaluating the role of disulfide bridges in protein folding and stability Int J Pept Protein Res, 1992; 40: 94-207
25. Ferrer, M, Barany, G, Woodward, C. Partially folded, molten globule and molten coil states of bovine pancreatic trypsin inhibitor Nat Struct Biol, 1995; 2: 211-217
26. Garrett, TPJ, McKern, NM, Lou, M, Elleman, TC, Adams, TE, Lovrecz, GO, Zhu, H-J, Walker, F, Hoyne, PA, Jorissen, RN, Nice, EC, Burgess, AW, Ward, CW. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor-α Cell, 2002; 110: 763-773
27. Garrett, TPJ, McKern, NM, Lou, M, Elleman, TC, Adams, TE, Lovrecz, GO, Kofler, M, Jorissen, RN, Nice, EC, Burgess, AW, Ward, CW. The first 3 domains of ErbB2 ectodomain adopt a pseudo-active form of the receptor Mol Cell, 2003; 11: 495-505
28. Gregory, H, Thomas, CE, Young, JA, Willshire, IR, Garner, A. The contribution of the C-terminal undecapeptide sequence of urogastron-epidermal growth factor to its biological action Regul Peptides, 1988; 22: 217-226
29. Groenen, LC, Nice, EC, Burgess, AW. Structure-function relationships for the EGF/TGF-alpha family of mitogens Growth Factors, 1994; 11: 235-257
30. Han, KH, Ferretti, JA, Niu, CH, Lokeshwar, V, Clarke, R, Katz, D. Conformational and receptor binding properties of human EGF and TGF-alpha second loop fragments J Mol Recognit, 1988; 1: 116-123
31. Heath, WF, Merrifield, RB. A synthetic approach to structure-function relationships in the murine epidermal growth factor molecule Proc Natl Acad Sci USA, 1986; 83: 6367-6371
32. Holladay, LA, Savage, CR, Cohen, S, Puett, D. Conformation and unfolding thermodynamics of epidermal growth factor and derivatives Biochemistry, 1976; 15: 2624-2633
33. Husbyn, M, Orning, L, Sakariassen, KS, Fischer, PM. Peptides corresponding to the second epidermal growth factor-like domain of human blood coagulation factor VII: Synthesis, folding and biological activity J Pept Res, 1997; 50: 475-482
34. Hynes, NE, Stern, DF. The biology of erbB-2/neu/HER-2 and its role in cancer Biochim Biophys Acta, 1994; 1198: 165-184
35. Jacobsen, NE, Abadi, N, Sliwkowski, MX, Reilly, D, Skelton, NJ, Fairbrother, WJ. High-resolution solution structure of the EGF-like domain of heregulin-alpha Biochemistry, 1996; 35: 3402-3417
36. Jenner, J, Meier, BH, Bachmann, P, Ernst, RR. Investigation of chemical exchange processes by two dimensional NMR spectroscopy J Chem Phys, 1979; 71: 4546-4553
37. Karim, CB, Paterlini, MG, Reddy, LG, Hunter, GW, Barany, DD, Thomas, DD. Role of cysteine residues in structural stability and function of a transmembrane helix bundle J Biol Chem, 2001; 276: 38814-38819
38. Komoriya, A, Hortsch, M, Meyers, C, Smith, M, Kanety, H, Schlessinger, J. Biologically active synthetic fragments of epidermal growth factor: Localization of a major receptor-binding region Proc Natl Acad Sci USA, 1984; 81: 1351-1355
39. Kumar, A, Ernst, RR, Wuthrich, K. A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules Biochem Biophys Res Commun, 1980; 95: 1-6
40. Lazar, E, Vicenzi, E, Van Obberghen-Schilling, E, Wolff, B, Dalton, S, Watanabe, S, Sporn, MB. Transforming growth factor alpha: An aromatic side chain at position 38 is essential for biological activity Mol Cell Biol, 1989; 9: 860-864
41. Lemmon, MA, Bu, Z, Ladbury, JE, Zhou, M, Pinchasi, D, Lax, I, Engelman, DM, Schlessinger, J. Two EGF molecules contribute additively to stabilization of the EGFR dimer EMBO J, 1997; 16: 281-294
42. Louie, GV, Yang, W, Bowman, ME, Choe, S. Crystal structure of the complex of diphtheria toxin with an extracellular fragment of its receptor Mol Cell, 1997; 1: 67-78
43. Lu, HS, Chai, JJ, Li, M, Huang, BR, He, CH, Bi, RC. Crystal structure of human epidermal growth factor and its dimerization J Biol Chem, 2001; 276: 34913-34917
44. Matsuzaki, K, Nakayama, M, Fukui, M, Otaka, A, Funakoshi, S, Fujii, N, Bessho, K, Miyajima, K. Role of disulfide linkages in tachyplesin-lipid interactions Biochemistry, 1993; 32: 11704-11710
45. McInnes, C, Hoyt, DW, Harkins, RN, Pagila, RN, Debanne, MT, O'Connor-McCourt, M, Sykes, BD. NMR study of the transforming growth factor-alpha (TGF-alpha)-epidermal growth factor receptor complex. Visualization of human TGF-alpha binding determinants through nuclear Overhauser enhancement analysis J Biol Chem, 1996; 271: 32204-32211
46. McInnes, C, Wang, J, Al Moustafa, AE, Yansouni, C, O'Connor-McCourt, M, Sykes, BD. Minimization of transforming growth factor-alpha (TGF-alpha) through NMR analysis of the receptor-bound ligand. Design, solution structure, and activity of TGF-alpha 8-50 J Biol Chem, 1998; 273: 27357-27363
47. McInnes, C, Grothe, S, O'Connor-McCourt, M, Sykes, BD. NMR study of the differential contributions of residues of transforming growth factor alpha to association with its receptor Protein Eng, 2000; 13: 143-147
48. Miura, K, Doura, H, Aizawa, T, Tada, H, Seno, M, Yamada, H, Kawano, K. Solution structure of betacellulin, a new member of EGF-family ligands Biochem Biophys Res Commun, 2002; 294: 1040-1046
49. Montelione, GT, Wuthrich, K, Nice, EC, Burgess, AW, Scheraga, HA. Indentification of two anti-parallel β-sheet conformations in the solution structure of murine epidermal growth factor by proton magnetic resonance Proc Natl Acad Sci USA, 1986; 83: 8594-8598
50. Montelione, GT, Wuthrich, K, Nice, EC, Burgess, AW, Scheraga, HA. Solution structure of murine epidermal growth factor: Determination of the polypeptide backbone chain-fold by nuclear magnetic resonance and distance geometry Proc Natl Acad Sci USA, 1987; 84: 5226-5230
51. Montelione, GT, Wuthrich, K, Burgess, AW, Nice, EC, Wagner, G, Gibson, KD, Scheraga, HA. Solution structure of murine epidermal growth factor determined by NMR spectroscopy and refined by energy minimization with restraints Biochemistry, 1992; 31: 236-249
52. Nagata, K, Kohda, D, Hatanaka, H, Ichikawa, S, Matsuda, S, Yamamoto, T, Suzuki, A, Inagaki, F. Solution structure of the epidermal growth factor-like domain of heregulin-alpha, a ligand for p180erbB-4 EMBO J, 1994; 13: 3517-3523
53. Narhi, LO, Arakawa, T, McGinley, MD, Rohde, MF, Westcott, KR. Circular dichroism of reduced and oxidized recombinant human epidermal growth factor Int J Pept Protein Res, 1992; 39: 182-187
54. Nice, EC. Micropreparative LC of proteins Nature, 1990; 348: 462-463
55. Nice, EC. Micropreparative HPLC of proteins and peptides: Principles and applications Biopolymers (Peptide Science), 1996; 40: 319-341
56. Nice, EC, Domagala, T, Fabri, L, Nerrie, M, Walker, F, Jorissen, RN, Burgess, AW, Cui, D-F, Zhang, YS. Rapid microscale enzymic semisynthesis of epidermal growth factor (EGF) analogues Growth Factors, 2002; 20: 71-80
57. Normanno, N, Bianco, C, De Luca, A, Salomon, DS. The role of EGF-related peptides in tumor growth Front Biosci, 2001; 6: D685-D707
58. Normanno, N, Bianco, C, De Luca, A, Maiello, MR, Salomon, DS. Target-based agents against ErbB receptors and their ligands: A novel approach to cancer treatment Endocr Relat Cancer, 2003; 10: 1-21
59. Odaka, M, Kohda, D, Lax, I, Schlessinger, J, Inagaki, F. Ligand-binding enhances the affinity of dimerization of the extracellular domain of the epidermal growth factor receptor J Biochem (Tokyo), 1997; 122: 116-121
60. Ogiso, H, Ishitani, R, Nureki, O, Fukai, S, Yamanaka, M, Kim, JH, Saito, K, Sakamoto, A, Inoue, M, Shirouzu, M, Yokoyama, S. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains Cell, 2002; 110: 775-787
61. Ozawa, F, Friess, H, Tempia-Caliera, A, Kleeff, J, Buchler, MW. Growth factors and their receptors in pancreatic cancer Teratog Carcinog Mutagenet, 2001; 21: 27-44
62. Piotto, M, Saudek, V, Sklenar, V. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions J Biomol NMR, 1992; 2: 661-665
63. van de Poll, ML, van Vugt, MJ, Lenferink, AE, van Zoelen, EJ. Insertion of Argos sequences into the B-loop of epidermal growth factor results in a low-affinity ligand with strong agonistic activity Biochemistry, 1997; 36: 7425-7431
64. van de Poll, ML, van Vugt, MJ, Lenferink, AE, van Zoelen, EJ. Identification of the minimal requirements for binding to the human epidermal growth factor (EGF) receptor using chimeras of human EGF and an EGF repeat of Drosophila Notch J Biol Chem, 1998; 273: 16075-16081
65. Prigent, SA, Lemoine, NR. The type 1 (EGFR-related) family of growth factor receptors and their ligands Prog Growth Factor Res, 1992; 4: 1-24
66. Qi, CF, Liscia, DS, Normanno, N, Merlo, G, Johnson, GR, Gullick, WJ, Ciardiello, F, Saeki, T, Brandt, R, Kim, N. Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas Br J Cancer, 1994; 69: 903-910 et al.
67. Riese, DJ, Stern, DF. Specificity within the EGF family/ErbB receptor family signaling network Bioessays, 1998; 20: 41-48
68. Rock, FL, Li, X, Chong, P, Ida, N, Klein, M. Roles of disulfide bonds in recombinant human interleukin 6 conformation Biochemistry, 1994; 5146-5154
69. Saeki, T, Stromberg, K, Qi, CF, Gullick, WJ, Tahara, E, Normanno, N, Ciardiello, F, Kenney, N, Johnson, GR, Salomon, DS. Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors Cancer Res., 1992; 52: 3467-3473
70. Sato, K, Nakamura, T, Mizuguchi, M, Miura, K, Tada, M, Aizawa, T, Gomi, T, Miyamoto, K, Kawano, K. Solution structure of epiregulin and the effect of its C-terminal domain for receptor binding affinity FEBS Lett, 2003; 53: 232-238
71. Scanlon, DB, Eefting, M, Lloyd, CJ, Burgess, AW, Simpson, RJ. Synthesis of biologically-active human transforming growth factor-alpha by fluorenylmethoxycarbonyl solid phase peptide chemistry J Chem Soc: Chem Commun, 1987; 25: 516-518
72. Schlessinger, J. Cell signaling by receptor tyrosine kinases Cell, 2000; 103: 211-225
73. Schlessinger, J. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor Cell, 2002; 110: 669-672
74. Schnolzer, M, Alewood, P, Jones, A, Alewood, D, Kent, SB. In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences Int J Pept Protein Res, 1992; 40: 180-193
75. Shin, SY, Shimizu, M, Ohtaki, T, Munekata, E. Synthesis and biological activity of N-terminal-truncated derivatives of human epidermal growth factor (h-EGF) Peptides, 1995; 16: 205-210
76. Simpson, RJ, Smith, JA, Moritz, RL, O'Hare, MJ, Rudland, PS, Morrison, JR, Lloyd, CJ, Grego, B, Burgess, AW, Nice, EC. Rat epidermal growth factor. Complete amino acid sequence: Homology with the corresponding murine and human proteins but truncated at both ends Eur J Biochem, 1985; 153: 629-637
77. Spetzler, JC, Rao, C, Tam, JP. A novel strategy for the synthesis of the cysteine-rich protective antigen of the malaria merozoite surface protein (MSP-1). Knowledge-based strategy for disulfide formation Int J Pept Protein Res, 1994; 43: 351-358
78. Tam, JP. Synthesis of biologically active transforming growth factor alpha Int J Pept Protein Res, 1987; 29: 421-431
79. Tam, JP, Marquardt, H, Rosberger, DF, Wong, TW, Todaro, GJ. Synthesis of biologically active rat transforming growth factor I Nature, 1984; 309: 376-378
80. Tam, JP, Sheikh, MA, Solomon, DS, Ossowski, L. Efficient synthesis of human type alpha transforming growth factor: Its physical and biological characterization Proc Natl Acad Sci USA, 1986; 83: 8082-8086
81. Tam, JP, Wu, C-R, Liu, W, Zhang, J-W. Disulfide bond formation in peptides by dimethylsulphoxide. Scope and aapplication J Am Chem Soc, 1991; 86: 4099-4103
82. Walker, F, Orchard, SG, Jorissen, RN, Hall, NE, Zhang, HH, Hoyne, PA, Adams, TE, Johns, TG, Ward, C, Garrett, TP, Zhu, HJ, Nerrie, M, Scott, AM, Nice, EC, Burgess, AW. CR1/CR2 interactions modulate the functions of the cell-surface epidermal growth factor receptor J Biol Chem, 2004; Mar 11 (Epub ahead of print)
83. Winter, J, Lilie, H, Rudolph, R. Renaturation of human proinsulin-a study on refolding and conversion to insulin Anal Biochem, 2002; 310: 148-155
84. Wishart, DS, Sykes, BD, Richards, FM. Simple techniques for the quantification of protein secondary structure by 1H NMR spectroscopy FEBS Lett, 1991; 293: 72-80
85. Woo, DD, Clark-Lewis, I, Chait, BT, Kent, SB. Chemical synthesis in protein engineering: Total synthesis, purification and covalent structural characterization of a mitogenic protein, human transforming growth factor-alpha Protein Eng, 1989; 3: 29-37
86. Wuthrich, K. Sequential individual resonance assignments in the 1H-NMR spectra of polypeptides and proteins Biopolymers, 1983; 22: 131-138
87. Yarden, Y, Sliwkowski, MX. Untangling the ErbB signalling network Nat Rev Mol Cell Biol, 2001; 2: 127-137
88. Youngman, KM, Spencer, DB, Brems, DN, DeFelippis, MR. Kinetic analysis of the folding of human growth hormone. Influence of disulfide bonds J Biol Chem, 1995; 270: 19816-19822
89. van Zoelen, EJ, Stortelers, C, Lenferink, AE, Van de Poll, ML. The EGF domain: Requirements for binding to receptors of the ErbB family Vitam Horm, 2000; 59: 99-131